Results 51 to 60 of about 17,715 (228)

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Impact of socioeconomic factors on patient desire for LVAD therapy

, 2018
Purpose: While increased heart failure (HF) severity and poor quality of life (QOL) have been associated with the decision to receive a left ventricular assist device (LVAD), we examined if socioeconomic factors were associated with patient willingness ...
N. Gilotra, U. Jorde, Baldwin, J, J. Baldwin, Spino, C, S. Khalatbari, Forde-McLean, R, Jorde, U, McNamara, D, J. Thibodeau, I. Tchoukina, Mann, D, Horstmanshof, D, Shah, K, D.C. Haas, D. Lanfear, Thibodeau, J, D. McNamara, A. Lala, G.C. Stewart, Khalatbari, S, K.B. Shah, D.L. Mann, Tchoukina, I, Aaronson, K, Pamboukian, S, J.D. Estep, Lanfear, David, S. Pamboukian, D.A. Horstmanshof, Stewart, G, C.A. Spino, Estep, J, Haas, D, R. Forde-McLean, Gilotra, N, K.D. Aaronson, Lala, A   +37 more
core   +2 more sources

Assessing stress in LVAD recipients: Development of the LVAD Stress Questionnaire

The International Journal of Artificial Organs
Background: Patients receiving left ventricular assist device (LVAD) implantation can experience significant psychological stress that negatively impacts quality of life and treatment outcomes. Assessment of LVAD stress is critical for providing targeted interventions and advancing the relevant literature.
Connor Tripp, Laura Palmo, Daria Ebneter, Amanda Bowen, Paul B Tessmann, Qingqing Yin, Eileen J Burker   +6 more
openaire   +2 more sources

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Ablation of ventricular tachycardia in a patient with a left ventricular assist device

Türk Kardiyoloji Derneği Arşivi, 2020
The use of a left ventricular assist device (LVAD) as a bridge to heart transplantation (HTx) or as a destination therapy in patients with a contraindication for HTx is increasing.
Evrim Şimşek, Emin Evren Özcan, Emre Demir, Pelin Öztürk, Sanem Nalbantgil   +4 more
doaj   +1 more source

Myocardial inflammation is associated with impaired mitochondrial oxidative capacity in ischaemic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1246-1255, April 2025.
Abstract Aims Myocardial inflammation and impaired mitochondrial oxidative capacity are hallmarks of heart failure (HF) pathophysiology. The extent of myocardial inflammation in patients suffering from ischaemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM) and its association with mitochondrial energy metabolism are unknown.
Julius Borger, Elric Zweck, Constanze Moos, Patrick Horn, Fabian Voß, Heinz‐Peter Schultheiss, Jacob Eifer Møller, Udo Boeken, Hug Aubin, Artur Lichtenberg, Malte Kelm, Michael Roden, Amin Polzin, Ralf Westenfeld, Julia Szendroedi, Daniel Scheiber   +15 more
wiley   +1 more source

Percutaneous Intervention of LVAD Outflow Graft Obstruction and Thrombosis

Methodist DeBakey Cardiovascular Journal
Left ventricular assist devices serve as a salvage therapy for patients with advanced heart failure. Complications such as thrombosis and obstruction can lead to acute device malfunction, posing significant clinical risks. A multidisciplinary approach is
Andrew Takla, Fahad Eid, Mostafa Elbanna, Mohamed Magdi Eid, Akshay Joshi, Abdallah Bitar, Ryan Lydon, Scott Feitell   +7 more
doaj   +1 more source

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

ESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh, Katharina Koepsel, Julia W. Erath, Thomas Kuntz, Norbert Klein, Boldizsar Kovacs, Firat Duru, Ardan M. Saguner, Christian Blockhaus, Dong‐In Shin, Fabienne Kreimer, Michael Gotzmann, Hendrik Lapp, Thomas Beiert, Assem Aweimer, Andreas Mügge, Christel Weiß, Ibrahim El‐Battrawy, Ibrahim Akin   +18 more
wiley   +1 more source

LVAD pannus complicating destination therapy

, 2017
Despite advances in technology, ventricular assist devices still experience a number of complications limiting their long-term use. We present a 73-year-old woman implanted with a left ventricular assist device (LVAD) five years prior due to end-stage ...
Margaret Robin B. Cases, Davide Salina, Elizabeth Swiggum, Maya Ignaszewski, Anson Cheung, Michael A. Seidman, Andrew P. Ignaszewski   +6 more
core   +1 more source

Pexy of intraperitoneal LVAD driveline to relieve small bowel obstruction

, 2020
Background Left ventricular assist device (LVAD) implantation is a lifesaving intervention in advanced heart failure. However, LVAD is not without complication.
Urrechaga, Eva M, Lieberman, Howard M, Cresse, Stephen M, Banerjee, Monisha N, Cahill, Anthony, Cioci, Alessia C   +5 more
core   +1 more source